REACHING THE RIGHT MARKETS
Most of the feedback from MiraCradle’s
initial beta-testers was positive, and
gradually, word of mouth spread. Within
18 months of launch, the neonatal cooling
device had treated 170 babies in 54 hospitals in India.
The device has since gone through sev-
eral additional iterations. The phase-change
cooling layer now includes a temperature
gauge to inform hospital staff of when it
has reached the correct temperature for
use. This feature was added because the
test hospitals reported mixed results with
the speed and accuracy of cooling. In the
end, Pluss discovered that its design team
had not accounted for different regional
and hospital climates that could affect the
material’s temperature maintenance. As an
added precaution, the engineers also added
a second phase-change material with a
lower melting point of 21 degrees that can
be placed between the 29-degree layer and
the conduction mattress if the baby’s body
temperature does not drop sufficiently in
the initial 45-minute window.
With these improvements and additional
hospital feedback, the MiraCradle has
received medical device certification from
the International Standards Organization,
FIG 3: Map of MiraCradle’s trial sites
INDIA
• Ludhiana
• Jaipur
• • Anand
• Hyderabad
• Vellore
• Puducherry
• Chennai
• Thrissur
•
• Kolkata
• Patna
• Ranchi
• Gurgaon
Ahmedabad
Bangalore
• Manipal
D
E
M
A
N
D
|
A
S
M
E
G
L
O
B
A
L
D
E
V
E
L
O
P
M
E
N
T
R
E
V
I
E
W
